Disease areas:
  • nutrition and metabolism
Last updated:
Author(s):
Tatsuhiko Naito, Ken Suzuki, Jun Hirata, Yoichiro Kamatani, Koichi Matsuda, Tatsushi Toda, Yukinori Okada
Publish date:
12 March 2021
Journal:
Nature Communications
PubMed ID:
33712626

Abstract

Conventional human leukocyte antigen (HLA) imputation methods drop their performance for infrequent alleles, which is one of the factors that reduce the reliability of trans-ethnic major histocompatibility complex (MHC) fine-mapping due to inter-ethnic heterogeneity in allele frequency spectra. We develop DEEP*HLA, a deep learning method for imputing HLA genotypes. Through validation using the Japanese and European HLA reference panels (n = 1,118 and 5,122), DEEP*HLA achieves the highest accuracies with significant superiority for low-frequency and rare alleles. DEEP*HLA is less dependent on distance-dependent linkage disequilibrium decay of the target alleles and might capture the complicated region-wide information. We apply DEEP*HLA to type 1 diabetes GWAS data from BioBank Japan (n = 62,387) and UK Biobank (n = 354,459), and successfully disentangle independently associated class I and II HLA variants with shared risk among diverse populations (the top signal at amino acid position 71 of HLA-DRβ1; P = 7.5 × 10−120). Our study illustrates the value of deep learning in genotype imputation and trans-ethnic MHC fine-mapping.

Related projects

We aim to explore the genetic background relevant to health-related conditions. Genetic background difference among populations also affects difference in disease susceptibility. We plan to…

Institution:
University of Tokyo, Japan

All projects